Skip to main content

Advertisement

Table 2 Univariate analysis of prognostic parameters for survival in patients with GC

From: GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway

Prognostic parameter HR 95% CI P value
Expression of GPAA1 (High vs Low) 0.735 0.530–1.019 0.045
Age (≥65 vs. < 65) 1.486 1.142–1.932 0.003
Gender (Male vs. Female) 0.871 0.662–1.147 0.326
TNM Stage (III-IV vs. I-II) 4.754 3.487–6.482 0.000
Tumor Size (≥4 cm vs. < 4 cm) 3.192 2.274–4.481 0.000
Pathology Grade (I, I-II, II vs. II-III, III) 1.288 0.961–1.725 0.090
Expression of ERBB2 (High vs Low) 1.137 0.855–1.511 0.003
Lymphatic metastasis (Present vs. Absent) 3.852 2.751–5.934 0.000
Distant metastasis (Present vs. Absent) 1.176 0.165–8.395 0.871
Vascular invasion (Present vs. Absent) 2.435 1.795–3.303 0.000
Perineuronal invasion (Present vs. Absent) 2.152 1.531–3.025 0.000
Histology (Poor vs. well & moderate) 0.833 0.638–1.807 0.179
  1. HR Hazard ratio, CI Confidence interval